Format

Send to

Choose Destination
Eur J Pharmacol. 2016 Oct 15;789:254-264. doi: 10.1016/j.ejphar.2016.07.032. Epub 2016 Jul 27.

Effects of andrographolide on intrahepatic cholestasis induced by alpha-naphthylisothiocyanate in rats.

Author information

1
Toxicology Graduate Program, Faculty of Science, Mahidol University, Bangkok, Thailand.
2
Department of Anatomy, Phramongkutklao College of Medicine, Bangkok, Thailand.
3
Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
4
Department of Chemistry, Faculty of Science, Ramkhamhaeng University, Bangkok, Thailand.
5
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
6
Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA. Electronic address: jittima.wee@mahidol.ac.th.

Abstract

Cholestasis is a cardinal manifestation of liver diseases but effective therapeutic approaches are limited. Therefore, alternative therapy for treating and preventing cholestatic liver diseases is necessary. Andrographolide, a promising anticancer drug derived from the medicinal plant Andrographis paniculata, has diverse pharmacological properties and multi-spectrum therapeutic applications. However, it is unknown whether andrographolide has a hepatoprotective effect on intrahepatic cholestasis. The aims of this study were to investigate the protective effect and possible mechanisms of andrographolide in a rat model of acute intrahepatic cholestasis induced by alpha-naphthylisothiocyanate (ANIT). Andrographolide was administered intragastrically for four consecutive days, with a single intraperitoneal injection of ANIT on the second day. Liver injury was evaluated biochemically and histologically together with hepatic gene and protein expression analysis. Rats pretreated with andrographolide prior to ANIT injection demonstrated lower levels of serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gamma-glutamyltransferase, as well as bilirubin and bile acids as compared to rats treated with ANIT alone. Andrographolide also decreased the incidence and extent of periductular fibrosis and bile duct proliferation. Analysis of protein expression in livers from andrographolide-treated cholestatic rats revealed markedly decreased expression of alpha-smooth muscle actin and nuclear factor kappa-B (NF-κB). In conclusion, andrographolide has a potent protective property against ANIT-induced cholestatic liver injury. The mechanisms that underlie this protective effect are mediated through down-regulation of NF-κB expression and inhibition of hepatic stellate cell activation. These findings suggest that andrographolide could be a promising therapeutic option in prevention and slowing down the progression of cholestatic liver diseases.

KEYWORDS:

Alpha-naphthylisothiocyanate; Alpha-naphthylisothiocyanate (PubChem CID: 11080); Andrographolide; Andrographolide (PubChem CID: 5318517); Bile acid transporters; Bile duct; Carboxymethylcellulose Sodium (PubChem CID: 23706213); Cholestasis; Hepatic stellate cells

PMID:
27475677
DOI:
10.1016/j.ejphar.2016.07.032
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center